Enduring Material CME: Diabetes CME: The Amazing Race to Tight Glycemic Control: A Team Approach to Insulin Analog Therapy: International Medical Press
http://www.cmenetworks.com/cme/9875/1/Enduring-Material-CME-Diabetes-CME-The-Amazing-Race-to-Tight-Glycemic-Control-A-Team-Approach-to-Insulin-Analog-Therapy-International-Medical-Press/Page1.html
International Medical Press
International Medical Press (IMP) is a provider of independent continuing medical education with a 20-year history of delivering multi-format and multidisciplinary education. With a considerable breadth and depth of therapeutic expertise in the areas of diabetes, cardiometabolic risk, critical care, infectious diseases, and osteoporosis. IMP produces accurate, clinically relevant , unbiased content guaranteed through extensive content review processes. IMP’s continuing education providers units are accredited by the ACCME, ANCC, and ACPE and our staff are recognized as experts in the CME enterprise.
By International Medical Press
Published on 09/29/2008
CME Sponsor:
Location:
This is a web-based enduring material CME
Course Directors/Instructors:
Martin J. Abrahamson, MD
Associate Professor of Medicine
Harvard Medical School
Medical Director, Joslin Diabetes Center
Boston, MA
Number of Credits:
1.5 AMA PRA Category 1 Credit(s)TM
1.5 contact hours (0.15 CEUs)
Link
Detailed Description:
The prevalence of type 2 diabetes is increasing at an alarming rate, and timely treatment is needed to prevent or delay the devastating complications of this disease. Since type 2 diabetes is characterized by progressive ?-cell failure, earlier and more aggressive use of insulin therapy is often required to help patients meet their glycemic targets. As healthcare professionals (HCPs) face the growing number of patients who require more specialized and complex care, they will need practical strategies for managing complex patients.
The goal of this online activity is to reinforce the need for a team approach between HCPs and patients with type 2 diabetes to achieve tight glycemic control on insulin therapy. This online activity is based upon content originally presented at a symposium held on June 7, 2008, in San Francisco, California.
Learning Objectives:
The Amazing Race to Tight Glycemic Control: A Team Approach to Insulin Analog Therapy - Interactive Case Studies
This activity is intended for endocrinologists, diabetologists, diabetes educators, nurse practitioners, physician assistants, and other HCPs who treat patients with type 2 diabetes.
The Amazing Race to Tight Glycemic Control: A Team Approach to Insulin Analog Therapy - Interactive Case Studies
CME Sponsor:
International Medical Press
Location:
This is a web-based enduring material CME
Course Directors/Instructors:
Martin J. Abrahamson, MD
Associate Professor of Medicine
Harvard Medical School
Medical Director, Joslin Diabetes Center
Boston, MA
William Polonsky, PhD, CDE
Associate Clinical Professor
University of California, San Diego
President, Behavioral Diabetes Institute
San Diego, CA
Number of Credits:
1.5 AMA PRA Category 1 Credit(s)TM
1.5 contact hours (0.15 CEUs)
Link
Detailed Description:
The prevalence of type 2 diabetes is increasing at an alarming rate, and timely treatment is needed to prevent or delay the devastating complications of this disease. Since type 2 diabetes is characterized by progressive ?-cell failure, earlier and more aggressive use of insulin therapy is often required to help patients meet their glycemic targets. As healthcare professionals (HCPs) face the growing number of patients who require more specialized and complex care, they will need practical strategies for managing complex patients.
The goal of this online activity is to reinforce the need for a team approach between HCPs and patients with type 2 diabetes to achieve tight glycemic control on insulin therapy. This online activity is based upon content originally presented at a symposium held on June 7, 2008, in San Francisco, California.
Learning Objectives:
- Select appropriate insulin therapy for patients unable to achieve adequate glycemic control on oral agent therapy
- Explain how to advance insulin therapy if intensification is required
- Describe strategies to address challenges patients may face with initiation or intensification of insulin therapy